Chinese pharmaceutical company North China Pharmaceutical has announced the completion of a public offering of ten million short-term bonds to raise CNY1bn ($146.93m).
Priced at CNY100 ($14.69) each, the bonds are due 3 April 2018 and carry a rate of 5.3%.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Arena Pharmaceuticals has announced an underwritten public offering of common stock shares to raise $150m.
The US-based biopharmaceutical company plans to use the funds towards the clinical and pre-clinical development of its drug candidates.
Enterome Bioscience and Nestle’s subsidiary Nestle Health Science have announced the formation of a joint venture named Microbiome Diagnostics Partners (MDP).
The JV company will be engaged in the discovery, development and commercialisation of diagnostics in multiple disease areas.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataEnterome is a drug development company based in France, while Nestle Health Science is a US-based health science company.
